Evidence map›Paper›PMID 33884350›Full record

ArticleAfrican journal of infectious diseases2020

HIV-ASSOCIATED NON HODGKIN LYMPHOMA: A CASE SERIES STUDY FROM TURKEY.

Kayra Somay, Sidar Çöpür, Emre Osmanbaşoğlu, Helin Masyan, Harun Arslan, Olga Meltem Akay, Süda Tekin, Burhan Ferhanoğlu

Registry-linked trialOpen access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in African journal of infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06774495 (Cancer Prevalence and Outcomes in Individuals Living With HIV and AIDS), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06774495 completednot on this mapstarted 2024, after this paper: background citation

Cancer Prevalence and Outcomes in Individuals Living With HIV and AIDS: Multicenter BUHASDER Study

TypeobservationalSponsorKocaeli UniversityRan2024 to 2025Enrolled154ConditionsHiv, Cancer
3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Kayra SomayInternal Medicine Department, Koç University Medical School, İstanbul, Turkey.
Sidar ÇöpürKoç University Medical School, İstanbul, Turkey.
Emre OsmanbaşoğluHematology Department, Koç University Hospital, İstanbul, Turkey.
Helin MasyanInternal Medicine Department, Koç University Hospital, İstanbul, Turkey.
Harun ArslanInternal Medicine Department, Koç University Hospital, İstanbul, Turkey.
Olga Meltem AkayHematology Department, Koç University Medical School, Istanbul, Turkey.
Süda TekinInfectious Diseases and Clinical Microbiology Department, Koç University Medical School, Istanbul, Turkey.
Burhan FerhanoğluHematology Department, Koç University Medical School, Istanbul, Turkey.
Koç University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHuman immunodeficiency virus (HIV) is a global health concern with major risks for opportunistic infections and predisposition to malignancies including Kaposi sarcoma associated with Human Herpes Virus-8 (HHV-8) and non-Hodgkin lymphoma (NHL) commonly associated with Epstein Barr Virus (EBV). Although the exact mechanisms of predisposition to certain malignancies are unclear, HIV (+) cancer patients typically have poorer prognosis. MATERIALS AND

methodsWe included all five HIV positive NHL patients receiving antiretroviral therapy (ART) and chemotherapy in our clinic and aim to determine their follow-up outcomes associated with ART.

resultsThe use of ART in conjunction with chemotherapy regimens lead to better therapeutic outcome in our cases with no mortality over three years of follow-up despite high rates of poor prognostic factors and studies demonstrating 1-year survival rates of approximately 30% in HIV-associated lymphoma. No significant adverse effect has been recorded.

conclusionWe recommend use of ART along with chemotherapy regimens in HIV positive lymphoma patients for better treatment response.

Indexed as

anti-retroviral therapyHuman immunodeficiency viruslymphomanon-Hodgkin lymphoma

Identifiers

PMID33884350
PMCPMC8047295
OpenAlexW3046313071

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.